Clinical Trial

Impact of Specific Oligomeric Supplementation in Oncologic Patients Undergoing Radiotherapy With Malnutrition or at Risk.

Study acronym: NORMA
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated October 7, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
An observational, prospective, multicenter study to be conducted in 5 hospitals in Spain. Patients with cancer undergoing radiotherapy are malnourished or at risk of malnutrition. Due to the characteristics of their pathology or gastrointestinal disorders, the use of oligomeric nutritional formulas formulated with 100% hydrolyzed whey lactoprotein and a high MCT content is recommended as part of routine clinical practice. Patients will be followed for 12 weeks, with three visits: a baseline visit upon inclusion in the study, after 6 weeks and a final visit 12 weeks after the nutritional treatment starts.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-16.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-10-01
Trial Details
NCT Number NCT07035132
Lead Sponsor Outcomes'10
Collaborators: Nestlé Health Science Spain
Conditions Malnutrition in Elderly, Oncological Patients, Digestive Disorders
Enrollment 132 participants
Start Date 2025-08-15
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-07